OFMOM
STORY
To help build a world
where mothers and infants receive the
best care and health services
The prestigious legacy of 50 years of microbiome research and development, pioneered by the Lim’s family,is currently being succeeded and further advanced through tradition and innovation via COREE Group's global research centers in Italy, China, and SouthKorea.
SynterAct Technology 3 Strain Formula, co-developed by Dr. Lorenzo Morelli, a world renowned authority in probiotics, and COREE Italy's AAT Research center, demonstrates upmost synergyin both effectiveness and stability through the application of a unique blending ratio of probiotic strains.
between prebiotic activity and the gut microbiome environment through probiotic fermentation of food.
In the health industry, clinical studies are being conducted for the benefit of mothers and babies in ‘Maternal-Child Health Services' at Peking Union College Hospital in China, and for those suffering from diabetes and metabolic chronic diseases at the Roman Catholic University and the Gemelli Hospital in Italy.
for development of prevention, treatment, and care solutions using microbiome-based bacterial cultures.
To help build a world
where mothers and infants receive the
best care and health services